Study on serum free nucleic acid of patients with novel coronavirus pneumonia (COVID-19)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042634

Enrollment

Unknown

Registered

2021-01-24

Start date

2020-04-23

Completion date

Unknown

Last updated

2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Case Group:Serum free nucleic acid sequencing

control group: Serum free nucleic acid sequencing

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Blood samples of COVID-19 patients are collected in the Fifth Affiliated Hospital of Sun Yat-Sen University according to the latest edition of the diagnosis and treatment plan about COVID-19; 2. The remaining blood samples are collected from the clinical laboratory of the Fifth Affiliated Hospital of Sun Yat-Sen University as the control group, whose age and gender match patients in the case group.

Exclusion criteria

Exclusion criteria: 1. Lack of sample information; 2. Unable or fail to detect due to human error; 3. Abnormal results or failure in detection due to instrument or non-reagent quality problems; 4. The control group exclude blood samples from those with severe physical or organic brain disease.

Design outcomes

Primary

Measure	Time frame
Serum free nucleic acid sequencing;	—

Countries

China

Contacts

Public ContactPengfei Pang

The Fifth Affiliated Hospital of Sun Yat-Sen University

pangpf@mail.sysu.edu.cn+86 18902536585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026